• Home
  • Study Details
By physician referral or invitation only

IV Ganaxolone for Patients with Status Epilepticus

The purpose of this study is to see how effective intravenous ganaxolone is at decreasing seizures in patients with status epilepticus when other antiseizure medications have not worked.

Age & Gender

  • 12 years ~ 99 years
  • Male, Female

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Clio Rubinos
Neurology-Intensive Care Unit

Study Type

Clinical or Medical
Interventional

Study Topics

Brain, Head, Nervous System

IRB Number

22-3280

ClinicalTrials.gov

NCT04391569

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research